UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer

British journal of cancer, 2021-02, Vol.124 (3), p.552-563

2021

Volltextzugriff (PDF)

CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma

Cancer cell, 2020-03, Vol.37 (3), p.340-353.e6

2020

Volltextzugriff (PDF)

c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling

Cancer cell, 2018-02, Vol.33 (2), p.217-228.e4

2018

Volltextzugriff (PDF)

Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer

European journal of cancer (1990), 2021-04, Vol.147, p.74-83

2021

Volltextzugriff (PDF)

Afatinib restrains K-RAS-driven lung tumorigenesis

Science translational medicine, 2018-06, Vol.10 (446)

2018

Volltextzugriff (PDF)

An improved quantitative mass spectrometry analysis of tumor specific mutant proteins at high sensitivity

Proteomics (Weinheim), 2012-05, Vol.12 (9), p.1319-1327

2012

Volltextzugriff (PDF)

Personalized RNA Medicine for Pancreatic Cancer

Clinical cancer research, 2018-04, Vol.24 (7), p.1734-1747

2018

Volltextzugriff (PDF)

The effects of different endocrine disruptors defining compound-specific alterations of gene expression profiles in the developing testis

Reproductive toxicology (Elmsford, N.Y.), 2012-01, Vol.33 (1), p.106-115

2012

Volltextzugriff (PDF)

The expression patterns of genes involved in the RNAi pathways are tissue-dependent and differ in the germ and somatic cells of mouse testis

Biochimica et biophysica acta, 2008-05, Vol.1779 (5), p.306-311

2008

Volltextzugriff (PDF)

Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression

PloS one, 2015-11, Vol.10 (11), p.e0142631-e0142631

2015

Volltextzugriff (PDF)

Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes

Translational research : the journal of laboratory and clinical medicine, 2023-03, Vol.253, p.68-79

2023

Volltextzugriff (PDF)

CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma

Cancer cell, 2020-10, Vol.38 (4), p.584-584

2020

Volltextzugriff (PDF)

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

Oncotarget, 2017-05, Vol.8 (21), p.35289-35300

2017

Volltextzugriff (PDF)

Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft

Journal of clinical oncology, 2012-02, Vol.30 (4), p.e45-e48

2012

Volltextzugriff (PDF)

Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer

Pharmacology research & perspectives, 2014-12, Vol.2 (6), p.e00067-n/a

2014

Volltextzugriff (PDF)

Gene-expression profiling in pancreatic cancer

Expert review of molecular diagnostics, 2010-07, Vol.10 (5), p.591-601

2010

Volltextzugriff (PDF)

Gene silencing by RNAi in mouse Sertoli cells

Reproductive biology and endocrinology, 2008-07, Vol.6 (1), p.29-29, Article 29

2008

Volltextzugriff (PDF)

OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models

Clinical cancer research, 2020-07, Vol.26 (13), p.3420-3430

2020

Volltextzugriff (PDF)

Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment

Clinical cancer research, 2014-05, Vol.20 (9), p.2476-2484

2014

Volltextzugriff (PDF)

Changes in vinexin expression patterns in the mouse testis induced by developmental exposure to 17beta-estradiol

Biology of reproduction, 2007-10, Vol.77 (4), p.605-613

2007

Volltextzugriff (PDF)

Transcriptional dissection of pancreatic tumors engrafted in mice

Genome medicine, 2014-04, Vol.6 (4), p.27-27

2014

Volltextzugriff (PDF)

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

Science translational medicine, 2020-10, Vol.12 (565)

2020

Volltextzugriff (PDF)

SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial

Clinical cancer research, 2015-11, Vol.21 (21), p.4811-4818

2015

Volltextzugriff (PDF)

Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective

Public health genomics, 2017-01, Vol.20 (2), p.81-91

2017

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Humans
(21)
Animals
(20)
Oncology
(19)
Mice
(17)
Male
(15)
Tumors
(13)
Female
(12)
Cell Biology
(10)
Mutation
(8)
Cancer
(7)
Cell Line, Tumor
(7)
Patients
(7)
Xenograft Model Antitumor Assays
(7)
Pancreatic Neoplasms - Genetics
(6)
Antineoplastic Agents - Therapeutic Use
(5)
Disease Models, Animal
(5)
Gene Expression
(5)
Genetic Aspects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer

CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma

c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling

Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer

Afatinib restrains K-RAS-driven lung tumorigenesis

An improved quantitative mass spectrometry analysis of tumor specific mutant proteins at high sensitivity

Personalized RNA Medicine for Pancreatic Cancer

The effects of different endocrine disruptors defining compound-specific alterations of gene expression profiles in the developing testis

The expression patterns of genes involved in the RNAi pathways are tissue-dependent and differ in the germ and somatic cells of mouse testis

Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers

Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression

Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes

CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft

Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer

Gene-expression profiling in pancreatic cancer

Gene silencing by RNAi in mouse Sertoli cells

OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models

Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment

Changes in vinexin expression patterns in the mouse testis induced by developmental exposure to 17beta-estradiol

Transcriptional dissection of pancreatic tumors engrafted in mice

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial

Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective

Suchergebnisse filtern